Results 331 to 340 of about 896,723 (386)

The gut microbiota and sleep in infants: a focus on diurnal rhythmicity patterns

Kerff F, Mühlematter C, Adamov A, Fast D, Plüss S, Zimmermann P, Kurth S, Bokulich NA.   +7 more
europepmc   +1 more source

Gut microbiota-mediated modulation of host amino acid availability and metabolism. [PDF]

Gut Microbes
Han Z, Zhao L, Hu Q, Hung I, Liu C, Liu S, Mei X, Zeng X, Bin P, Wang J.   +9 more
europepmc   +1 more source

RORγt‐APCs: The New Masters of Oral Tolerance

Barrier Immunity, EarlyView.
ABSTRACT Oral tolerance is defined by the hypo‐responsiveness of our body to fed antigens, and its failure can lead to immune‐mediated diseases, such as allergy, chronic inflammation and autoimmune diseases. Decades of research have demonstrated that antigen‐presenting cells (APCs) promote oral tolerance by inducing regulatory T cells (Tregs) and/or ...
Thierry Gauthier, WanJun Chen
wiley   +1 more source

Gut microbiota contribute to high-altitude adaptation in tree sparrows. [PDF]

mSystems
Bo T, Song G, Zhang M, Xu X, Duan J, She H, Fang Y, Li W, Wen J, Liu J, Wang D, Lei F.   +11 more
europepmc   +1 more source

Redefining the Skin Barrier: A Microbiome‐Integrated Multilayered Defense Model

Barrier Immunity, EarlyView.
ABSTRACT The skin constitutes a dynamic interface orchestrating a sophisticated multilayered defense system comprising physical, chemical, immune, and microbial barriers. This review synthesizes current understanding of the structural and functional integration of these barriers, emphasizing their synergistic interactions in maintaining cutaneous ...
Jingjing Xia, Mathias Hochgerner, Qingzhen Wei, Xian'ge Zhong, Jiucun Wang   +4 more
wiley   +1 more source

Gut microbiota and stress ulcers: unraveling the neurotransmitter connection. [PDF]

Front Neurosci
Abdel-Sater KA, Hassan HA.
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Cholecystectomy-related gut microbiota dysbiosis exacerbates colorectal tumorigenesis. [PDF]

Nat Commun
Tang B, Li S, Li X, He J, Zhou A, Wu L, Xiao X, Wang S, Jiang H, Jian J, Hou Z, Ge Y, Lei Y, Zhou J, Tu D, Lu C, Yang M, Yang S.   +17 more
europepmc   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Gut microbiota as a predictive tool for outcomes in IgA nephropathy. [PDF]

Ren Fail
Dong Y, Yan G, Zhang Y, Zhou Y, Shang J.
europepmc   +1 more source